Microcatheter-facilitated alcohol septal ablation for residual left ventricular outflow tract obstruction
Open Access
- 1 September 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (9) , ytae485
Abstract
A 65-year-old female patient with obstructive hypertrophic cardiomyopathy was referred to our hospital for septal reduction therapy. Echocardiography revealed left ventricular outflow tract obstruction (LVOTO) with systolic anterior motion of the mitral leaflet and no abnormal structure related to the obstruction. Coronary angiography identified the major septal branch originating from the left anterior descending artery to be a target branch for alcohol septal ablation (ASA) (Panel A). In the initial procedure, under septal branch occlusion by a 2 mm over-the-wire balloon (see Movie S1), the culprit myocardial bulge was ablated with 2 mL of ethanol (Panels B and C), with the resting gradient reduced from 100 to 3 mmHg and peak serum creatine kinase level of 1330 U/L. One year later, exertional dyspnoea recurred with LVOTO at the most-basal septum. In coronary angiography, a sub-branch from the left circumflex artery was deemed to be a target vessel for ASA (Panel D). In the repeat procedure, we used a Corsair Pro microcatheter [tip: 1.3 Fr (0.42 mm), shaft: 2.6 Fr (0.87 mm), Asahi Intec, Nagoya, Japan]. A tip-injection into the microcatheter wedged on the sub-branch confirmed the perfusion to the culprit basal septum and no ethanol leakage to any other vessel (Panel E, Movie S2). Injection of 1.2 mL of ethanol resulted in ablation of the residual myocardial bulge (Panel F). The gradient reduced from 42 to 2 mmHg at rest and 87 to 6 mmHg on Valsalva with peak serum creatine kinase level of 453 U/L. Cardiac magnetic resonance imaging proved the additional ablation of the most-basal septum (Panels G and H, arrowheads) next to the scar of the initial ASA (Panels G and I, arrows). No relapse of LVOTO was observed for three-year follow-up.Keywords
Funding Information
- Sakakibara Heart Foundation Cardiovascular Research